Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses
Research and development	$ 3,559,635	$ 2,278,424
General and administrative	5,895,585	4,603,514
Total operating expenses	9,455,220	6,881,938
Loss from operations	(9,455,220)	(6,881,938)
Other income (expense)
Interest expense	(16,505)	(1,591,244)
Interest income	152,631
Total other income (expense), net	136,126	(1,591,244)
Net loss	$ (9,319,094)	$ (8,473,182)
Net loss per share:
Basic	$ (7.14)	$ (18.72)
Diluted	$ (7.14)	$ (18.72)
Weighted average number of common shares outstanding:
Basic	1,305,437	452,686
Diluted	1,305,437	452,686